James M. O’Brien Appointed Chief Financial Officer at Mesoblast

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that in connection with the Company’s transition to a fully ...

Poets&Quants’ 2026 World’s Best MBA Programs For Entrepreneurship

Student founders show off their ventures at the 2025 Skandalaris Launchpad Expo at Washington University in St. Louis. Photo ...